Similar articles for PMID: 19457927

Year	Number of Results
1958	1
1991	2
1993	2
1994	4
1995	7
1996	8
1997	2
1998	3
1999	4
2000	1
2001	4
2002	8
2003	6
2004	9
2005	16
2006	22
2007	40
2008	74
2009	94
2010	8
2011	6
2012	7
2013	7
2014	9
2015	9
2016	6
2017	12
2018	10
2019	13
2020	6
2021	11
2022	8
2023	1
2024	0

1

Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.

Belville C, Maréchal JD, Pennetier S, Carmillo P, Masgrau L, Messika-Zeitoun L, Galey J, Machado G, Treton D, Gonzalès J, Picard JY, Josso N, Cate RL, di Clemente N. Belville C, et al. Hum Mol Genet. 2009 Aug 15;18(16):3002-13. doi: 10.1093/hmg/ddp238. Epub 2009 May 20. Hum Mol Genet. 2009. PMID: 19457927

2

Anti-Müllerian hormone receptor defect.

di Clemente N, Belville C. di Clemente N, et al. Best Pract Res Clin Endocrinol Metab. 2006 Dec;20(4):599-610. doi: 10.1016/j.beem.2006.09.004. Best Pract Res Clin Endocrinol Metab. 2006. PMID: 17161334 Review.

3

Constitutive negative regulation in the processing of the anti-Müllerian hormone receptor II.

Hirschhorn T, di Clemente N, Amsalem AR, Pepinsky RB, Picard JY, Smorodinsky NI, Cate RL, Ehrlich M. Hirschhorn T, et al. J Cell Sci. 2015 Apr 1;128(7):1352-64. doi: 10.1242/jcs.160143. Epub 2015 Feb 6. J Cell Sci. 2015. PMID: 25663701

4

Differential expression of anti-Müllerian hormone (amh) and anti-Müllerian hormone receptor type II (amhrII) in the teleost medaka.

Klüver N, Pfennig F, Pala I, Storch K, Schlieder M, Froschauer A, Gutzeit HO, Schartl M. Klüver N, et al. Dev Dyn. 2007 Jan;236(1):271-81. doi: 10.1002/dvdy.20997. Dev Dyn. 2007. PMID: 17075875 Free article.

5

Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor.

Imbeaud S, Faure E, Lamarre I, Mattéi MG, di Clemente N, Tizard R, Carré-Eusèbe D, Belville C, Tragethon L, Tonkin C, Nelson J, McAuliffe M, Bidart JM, Lababidi A, Josso N, Cate RL, Picard JY. Imbeaud S, et al. Nat Genet. 1995 Dec;11(4):382-8. doi: 10.1038/ng1295-382. Nat Genet. 1995. PMID: 7493017

6

[Genetics and molecular pathology of anti-Mullerian hormone and its receptor].

Picard JY, Belville C. Picard JY, et al. J Soc Biol. 2002;196(3):217-21. J Soc Biol. 2002. PMID: 12462075 Review. French.

7

AMH and AMH receptor defects in persistent Müllerian duct syndrome.

Josso N, Belville C, di Clemente N, Picard JY. Josso N, et al. Hum Reprod Update. 2005 Jul-Aug;11(4):351-6. doi: 10.1093/humupd/dmi014. Epub 2005 May 5. Hum Reprod Update. 2005. PMID: 15878900 Review.

8

Molecular analysis of the anti-Müllerian hormone, the anti-Müllerian hormone receptor, and galactose-1-phosphate uridyl transferase genes in patients with the Mayer-Rokitansky-Küster-Hauser syndrome.

Zenteno JC, Carranza-Lira S, Kofman-Alfaro S. Zenteno JC, et al. Arch Gynecol Obstet. 2004 May;269(4):270-3. doi: 10.1007/s00404-002-0456-7. Epub 2002 Dec 19. Arch Gynecol Obstet. 2004. PMID: 15221321

9

Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene.

Hoshiya M, Christian BP, Cromie WJ, Kim H, Zhan Y, MacLaughlin DT, Donahoe PK. Hoshiya M, et al. Birth Defects Res A Clin Mol Teratol. 2003 Oct;67(10):868-74. doi: 10.1002/bdra.10091. Birth Defects Res A Clin Mol Teratol. 2003. PMID: 14745940

10

Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.

Shimanuki T, Hara T, Furuya T, Imamura T, Miyazono K. Shimanuki T, et al. Oncogene. 2007 May 17;26(23):3311-20. doi: 10.1038/sj.onc.1210123. Epub 2006 Dec 4. Oncogene. 2007. PMID: 17146441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

369 results

Results by year